DE69911017D1 - Arylsulfonanilid-phosphate - Google Patents
Arylsulfonanilid-phosphateInfo
- Publication number
- DE69911017D1 DE69911017D1 DE69911017T DE69911017T DE69911017D1 DE 69911017 D1 DE69911017 D1 DE 69911017D1 DE 69911017 T DE69911017 T DE 69911017T DE 69911017 T DE69911017 T DE 69911017T DE 69911017 D1 DE69911017 D1 DE 69911017D1
- Authority
- DE
- Germany
- Prior art keywords
- agents
- compositions
- arylsulfonanilid
- phosphate
- infrections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9068198P | 1998-06-25 | 1998-06-25 | |
US90681P | 1998-06-25 | ||
PCT/US1999/013759 WO1999067258A1 (en) | 1998-06-25 | 1999-06-16 | Arylsulfonanilide phosphates |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69911017D1 true DE69911017D1 (en) | 2003-10-09 |
DE69911017T2 DE69911017T2 (de) | 2004-07-08 |
Family
ID=22223830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69911017T Expired - Fee Related DE69911017T2 (de) | 1998-06-25 | 1999-06-16 | Arylsulfonanilid-phosphate |
Country Status (8)
Country | Link |
---|---|
US (2) | US6211167B1 (de) |
EP (1) | EP1090014B1 (de) |
JP (1) | JP2002518506A (de) |
AT (1) | ATE248845T1 (de) |
AU (1) | AU763687B2 (de) |
CA (1) | CA2335559A1 (de) |
DE (1) | DE69911017T2 (de) |
WO (1) | WO1999067258A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ331941A (en) * | 1996-02-22 | 2000-04-28 | Tularik Inc | Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis |
CO5170498A1 (es) * | 1999-05-28 | 2002-06-27 | Abbott Lab | Biaril sulfonamidas son utiles como inhibidores de proliferacion celular |
DE60019937T2 (de) * | 1999-07-29 | 2006-05-04 | Amgen, Inc., Thousands Oaks | Kombinationstherapie mit Pentafluorobenzolsulfonamid und Platin-Derivaten |
AU781563B2 (en) * | 2000-02-02 | 2005-06-02 | Warner-Lambert Company | Dual inhibitors of cholesterol ester and wax ester synthesis for sebaceous gland disorders |
AU2002234165A1 (en) | 2000-11-03 | 2002-05-27 | Tularik, Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
US20050250854A1 (en) * | 2000-11-03 | 2005-11-10 | Amgen Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
GB0224830D0 (en) * | 2002-10-24 | 2002-12-04 | Sterix Ltd | Compound |
DE102007052174A1 (de) * | 2007-10-30 | 2009-05-07 | Ovd Kinegram Ag | Folienelement zur Sicherung eines Gegenstandes |
WO2021099842A1 (en) * | 2019-11-22 | 2021-05-27 | 2692372 Ontario Inc. | Pentafluorobenzenesulfonamide derivatives and uses thereof |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1955207A (en) | 1931-09-16 | 1934-04-17 | Ig Farbenindustrie Ag | Mothproofing agent |
DE622494C (de) | 1932-01-03 | 1935-11-29 | I G Farbenindustrie Akt Ges | Verfahren zur Darstellung von Mono- bzw. Polynitropolysulfonen und deren Reduktionsprodukten |
US2358365A (en) | 1940-08-03 | 1944-09-19 | Parke Davis & Co | Sulphonamide derivatives and process for obtaining the same |
US2402623A (en) | 1943-06-24 | 1946-06-25 | Rohm & Haas | Nu-nitroaryl haloarylsulphonamides |
CH362688A (de) | 1957-09-10 | 1962-06-30 | Geigy Ag J R | Verfahren zur Herstellung von neuen Arylsulfonarylamiden |
GB938890A (en) | 1961-02-03 | 1963-10-09 | Boots Pure Drug Co Ltd | New fungicidal compositions and compounds |
CH504416A (de) | 1966-12-05 | 1971-03-15 | Ciba Geigy Ag | Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen |
GB1242057A (en) | 1968-07-04 | 1971-08-11 | Ici Ltd | Derivatives of 4-hydroxytetrafluoropyridine and the use thereof as plant growth regulators |
NL174644C (nl) | 1970-04-13 | 1984-07-16 | Minnesota Mining & Mfg | Werkwijze ter bereiding van een herbicide verbinding; tevens werkwijze voor de bereiding van een preparaat met herbicide werking. |
DE3623184A1 (de) | 1986-07-10 | 1988-01-14 | Kali Chemie Ag | Verfahren zur herstellung von n-fluorsulfonamiden |
US4883914A (en) | 1987-08-17 | 1989-11-28 | American Cyanamid Company | Benzenesulfonyl carboxamide compounds useful as herbicidal agents |
DE3804990A1 (de) | 1988-02-18 | 1989-08-31 | Basf Ag | Herbizid wirksame, heterocyclisch substituierte sulfonamide |
JPH0651711B2 (ja) * | 1988-06-29 | 1994-07-06 | 株式会社大塚製薬工場 | ホスホン酸ジエステル誘導体 |
DE3905075A1 (de) | 1989-02-18 | 1990-08-30 | Hoechst Ag | Benzolsulfonamide und verfahren zu ihrer herstellung |
FR2645537B1 (fr) | 1989-04-05 | 1994-03-04 | Fabre Medicament Pierre | Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique |
FR2665440B1 (fr) | 1990-07-31 | 1994-02-04 | Lipha | Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant. |
US5189211A (en) | 1990-08-01 | 1993-02-23 | Taisho Pharmaceutical Co., Ltd. | Sulfonamide derivatives |
ATE167473T1 (de) | 1990-08-20 | 1998-07-15 | Eisai Co Ltd | Sulfonamid-derivate |
US5561122A (en) * | 1994-12-22 | 1996-10-01 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Combretastatin A-4 prodrug |
US5529989A (en) * | 1995-01-09 | 1996-06-25 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Pancratistatin prodrug |
NZ331941A (en) * | 1996-02-22 | 2000-04-28 | Tularik Inc | Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis |
DK0939627T3 (da) * | 1996-07-19 | 2003-10-13 | Tularik Inc | Pentaflourbenzensulfonamider og analoger |
US6284923B1 (en) * | 1997-08-22 | 2001-09-04 | Tularik Inc | Substituted benzene compounds as antiproliferative and cholesterol lowering action |
-
1999
- 1999-06-16 DE DE69911017T patent/DE69911017T2/de not_active Expired - Fee Related
- 1999-06-16 JP JP2000555910A patent/JP2002518506A/ja not_active Ceased
- 1999-06-16 AT AT99928777T patent/ATE248845T1/de not_active IP Right Cessation
- 1999-06-16 AU AU45768/99A patent/AU763687B2/en not_active Ceased
- 1999-06-16 EP EP99928777A patent/EP1090014B1/de not_active Expired - Lifetime
- 1999-06-16 WO PCT/US1999/013759 patent/WO1999067258A1/en active IP Right Grant
- 1999-06-16 CA CA002335559A patent/CA2335559A1/en not_active Abandoned
-
2000
- 2000-06-14 US US09/595,398 patent/US6211167B1/en not_active Expired - Fee Related
-
2001
- 2001-02-07 US US09/779,419 patent/US6417176B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1090014A1 (de) | 2001-04-11 |
ATE248845T1 (de) | 2003-09-15 |
CA2335559A1 (en) | 1999-12-29 |
EP1090014B1 (de) | 2003-09-03 |
US20010018430A1 (en) | 2001-08-30 |
DE69911017T2 (de) | 2004-07-08 |
JP2002518506A (ja) | 2002-06-25 |
AU763687B2 (en) | 2003-07-31 |
WO1999067258A1 (en) | 1999-12-29 |
US6211167B1 (en) | 2001-04-03 |
AU4576899A (en) | 2000-01-10 |
US6417176B2 (en) | 2002-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1038913A1 (en) | Arylsulfonanilide ureas | |
HK1021699A1 (en) | Pentafluorobenzenesulfonamides and analogs. | |
PT1005453E (pt) | Compostos de benzeno substituido como agentes de reducao antiproliferativa | |
EP0896533A4 (de) | Pentafluorobenzensulfonamiden und analoge | |
BG103417A (en) | Condensed pyrimidine bicyclic derivatives | |
TR200103016T2 (tr) | CDK2 önleyicileri olarak pirazolobenzodiazepinler | |
YU6602A (sh) | Pirimidin-2,4,6-trion metaloproteinazni inhibitori | |
EP1178988A4 (de) | Verbindungen und therapeutische methoden | |
TR200002625T2 (tr) | Vitronektin Reseptörü Antagonistleri | |
DE69911017D1 (en) | Arylsulfonanilid-phosphate | |
BG105003A (en) | Combinations of protein farnesyltransfer and hmg coa reductase inhibitors and their use to treat cancer | |
TWI262791B (en) | 6-methoxy-2-naphthylacetic acid prodrugs | |
AP2002002417A0 (en) | Pyrimidine-2,4,6-trione metalloproteinase inhibitors. | |
TR200100363T2 (tr) | Vitronektin reseptör antagonistleri. | |
HK1082727A1 (en) | 2" oxo-voruscharin and derivatives thereof | |
EP1285911A3 (de) | Arylsulfonylanilid-Harnstoffe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: AMGEN INC., THOUSAND OAKS, CALIF., US |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |